Literature DB >> 3023810

Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.

J H Brown, D Goldstein.   

Abstract

Carbachol is 100 times more potent for inhibiting cyclic AMP formation than for stimulating phosphoinositide (PI) hydrolysis in chick heart cells. To determine whether this reflects differences in agonist affinity of the receptor(s) coupled to the two responses, we measured these functional responses following removal of receptor reserve with propylbenzilycholine mustard (PrBCM). Conditions of PrBCM treatment that led to progressive loss of up to 95% of the [3H]-N-methylscopolamine-binding sites decreased the potency but not the maximal capacity of carbachol to inhibit cyclic AMP formation. In contrast, there was a marked decrease in the maximal PI response to carbachol. The KA for carbachol, calculated by measuring functional responses following receptor inactivation, was similar whether the cyclic AMP or the PI response was examined. These KA values (approximately 40 microM) were similar to the KD calculated by examining carbachol competition for [3H]-N-methylscopolamine-binding sites on the intact cell. PrBCM treatment also decreased the maximal effect of oxotremorine on cyclic AMP formation under conditions in which carbachol remained a full agonist for this response. We interpret our data as indicating that: there is much greater receptor reserve in the coupling of muscarinic receptors to adenylate cyclase than to PI hydrolysis; this, rather than differences in receptor affinity underlies the disparate dose-response relationships for the two responses; and differences in the effects of weak agonist on the two responses may also reflect differences in receptor reserve. We suggest that muscarinic receptors with the same affinity for carbachol interact with different efficiency with the transducers (Gi and Gx) that regulate adenylate cyclase and phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023810

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

Review 1.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

2.  Effects of phorbol dibutyrate on M currents and M current inhibition in bullfrog sympathetic neurons.

Authors:  D A Brown; P R Adams
Journal:  Cell Mol Neurobiol       Date:  1987-09       Impact factor: 5.046

3.  Vasoactive intestinal polypeptide and non-adrenergic, non-cholinergic inhibition in lower oesophageal sphincter of opossum.

Authors:  E E Daniel; L P Jager; J Jury
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.

Authors:  Philip D Fox; Shane T Hentges
Journal:  J Neurosci       Date:  2017-08-07       Impact factor: 6.167

5.  Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells.

Authors:  S P Baker; P J Scammells; L Belardinelli
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.

Authors:  J Zhang; L Belardinelli; K A Jacobson; D H Otero; S P Baker
Journal:  Mol Pharmacol       Date:  1997-09       Impact factor: 4.436

7.  Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?

Authors:  Christopher J Brinkerhoff; John R Traynor; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2008-08-08       Impact factor: 2.691

8.  Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?

Authors:  T P Kenakin; C Boselli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

9.  Differential time course for desensitization to muscarinic effects on K+ and Ca2+ channels.

Authors:  K Mubagwa; J C Gilbert; A J Pappano
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

10.  Mediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal vein.

Authors:  M Pfaffendorf; P A Van Zwieten
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.